Pharmaceutical Preparations 32 companies · $506.68B combined revenue
SIC 2834 · official SEC filings
| # | Ticker | Company | Mkt Cap* | Revenue | Net Income | Sector |
|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | $367.00B | $94.19B | $26.80B | Pharmaceutical Preparations |
| 2 | LLY | Eli Lilly & Co | $807.89B | $65.18B | $20.64B | Pharmaceutical Preparations |
| 3 | MRK | Merck & Co., Inc. | $198.05B | $65.01B | $18.25B | Pharmaceutical Preparations |
| #4 | ABBV | Abbvie Inc. | $325.06B | $61.16B | $1.82B | Pharmaceutical Preparations |
| #5 | PFE | Pfizer Inc | $138.00B | $50.91B | $7.77B | Pharmaceutical Preparations |
| #6 | CELG-RI | Bristol Myers Squibb Co | $94.19B | $48.19B | $7.05B | Pharmaceutical Preparations |
| #7 | TEVJF | Teva Pharmaceutical Industries Ltd | $18.16B | $17.26B | $1.41B | Pharmaceutical Preparations |
| #8 | REGN | Regeneron Pharmaceuticals, Inc. | $54.80B | $14.34B | $4.50B | Pharmaceutical Preparations |
| #9 | VTRS | Viatris Inc | $10.38B | $14.25B | $0.000000 | Pharmaceutical Preparations |
| #10 | VRTX | Vertex Pharmaceuticals Inc / Ma | $113.40B | $12.00B | $3.95B | Pharmaceutical Preparations |
| #11 | BHC | Bausch Health Companies Inc. | $2.00B | $10.27B | $157.00M | Pharmaceutical Preparations |
| #12 | ZTS | Zoetis Inc. | $69.23B | $9.47B | $2.67B | Pharmaceutical Preparations |
| #13 | BEIGF | Beone Medicines Ltd. | $14.70B | $5.34B | $286.93M | Pharmaceutical Preparations |
| #14 | ELAN | Elanco Animal Health Inc | $7.00B | $4.71B | $-232.00M | Pharmaceutical Preparations |
| #15 | JAZZ | Jazz Pharmaceuticals Plc | $6.25B | $4.27B | $-356.15M | Pharmaceutical Preparations |
| #16 | PRGO | Perrigo Co Plc | $3.65B | $4.25B | $-1.43B | Pharmaceutical Preparations |
| #17 | ALNY | Alnylam Pharmaceuticals, Inc. | $42.63B | $3.71B | $313.75M | Pharmaceutical Preparations |
| #18 | BMRN | Biomarin Pharmaceutical Inc | $6.70B | $3.22B | $348.90M | Pharmaceutical Preparations |
| #19 | UTHR | United Therapeutics Corp | $11.23B | $3.18B | $1.33B | Pharmaceutical Preparations |
| #20 | AMRX | Amneal Pharmaceuticals, Inc. | $1.70B | $3.02B | $72.06M | Pharmaceutical Preparations |
| #21 | SRPT | Sarepta Therapeutics, Inc. | $1.67B | $1.86B | $-412.23M | Pharmaceutical Preparations |
| #22 | PTCT | Ptc Therapeutics, Inc. | $3.35M | $1.73B | $682.64M | Pharmaceutical Preparations |
| #23 | ALKS | Alkermes Plc. | $4.66B | $1.48B | $241.66M | Pharmaceutical Preparations |
| #24 | INDV | Indivior Pharmaceuticals, Inc. | $1.83B | $1.24B | $210.00M | Pharmaceutical Preparations |
| #25 | PBH | Prestige Consumer Healthcare Inc. | $2.97B | $1.09B | $190.30M | Pharmaceutical Preparations |
| #26 | ACAD | Acadia Pharmaceuticals Inc | $2.30B | $1.07B | $391.00M | Pharmaceutical Preparations |
| #27 | MDGL | Madrigal Pharmaceuticals, Inc. | $5.60B | $958.40M | $-288.28M | Pharmaceutical Preparations |
| #28 | IONS | Ionis Pharmaceuticals Inc | $5.28B | $943.71M | $-229.39M | Pharmaceutical Preparations |
| #29 | ANIP | Ani Pharmaceuticals Inc | $1.30B | $883.37M | $78.34M | Pharmaceutical Preparations |
| #30 | HRMY | Harmony Biosciences Holdings, Inc. | $1.32B | $868.45M | $158.69M | Pharmaceutical Preparations |
| #31 | INSM | Insmed Inc | $21.10B | $606.42M | $-1.28B | Pharmaceutical Preparations |
| #32 | ABT | Abbott Laboratories | $232.17B | – | – | Pharmaceutical Preparations |